Evaluation of the expression level of 12/15 lipoxygenase and the related inflammatory factors (CCL5, CCL3) in respiratory syncytial virus infection in mice model

Microbial Pathogenesis

Volumn 109, Issue , 2017, Pages 209-213

  Salimi, Vahid ^a   Ramezani, Ali ^a   Mirzaei, Habibollah ^a   Tahamtan, Alireza ^a   Faghihloo, Ebrahim ^b   Rezaei, Farhad ^a   Naseri, Maryam ^a   Bont, Louis ^c   Mokhtari Azad, Talat ^a   Tavakoli Yaraki, Masoumeh ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

12 15 lipoxygenases; Chemokine; Inflammation; Respiratory syncytial virus

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; RANTES; 12-15-LIPOXYGENASE; CCL3 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; DISEASE MODEL; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; PATHOGENICITY; PNEUMOVIRUS; VIROLOGY;

ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; BRONCHOALVEOLAR LAVAGE FLUID; CELL LINE; CHEMOKINE CCL3; CHEMOKINE CCL5; CHEMOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; LUNG; MICE; MICE, INBRED BALB C; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER;

EID: 85020281957     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2017.05.045     Document Type: Article

References (30)

1. Brown, P.M., Schneeberger, D.L., Piedimonte, G., Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatr. Respir. Rev. 16 (2015), 232–240.
2. Geerdink, R.J., Pillay, J., Meyaard, L., Bont, L., Neutrophils in respiratory syncytial virus infection: a target for asthma prevention. J. Allergy Clin. Immunol. 136 (2015), 838–847.
3. Power, U.F., Huss, T., Michaud, V., Plotnicky-Gilquin, H., Bonnefoy, J.Y., Nguyen, T.N., Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice. J. Virol. 75 (2001), 12421–12430.
4. Blanco, J.C., Richardson, J.Y., Darnell, M.E., Rowzee, A., Pletneva, L., Porter, D.D., Prince, G.A., Cytokine and chemokine gene expression after primary and secondary respiratory syncytial virus infection in cotton rats. J. Infect. Dis. 185 (2002), 1780–1785.
5. Pazdrak, K., Olszewska-Pazdrak, B., Liu, T., Takizawa, R., Brasier, A.R., Garofalo, R.P., Casola, A., MAPK activation is involved in posttranscriptional regulation of RSV-induced CCL5 gene expression. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2002), L364–L372.
6. Thomas, L.H., Friedland, J.S., Sharland, M., Becker, S., Respiratory syncytial virus-induced CCL5 production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J. Immunol. 61 (1998), 1007–1016.
7. Olszewska-Pazdrak, B., Casola, A., Saito, T., Alam, R., Crowe, S.E., Mei, F., Ogra, P.L., Garofalo, R.P., Cell-specific expression of CCL5, MCP-1, and CCL3 by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J. Virol. 72 (1998), 4756–4764.
8. Koga, T., Sardina, E., Tidwell, R.M., Pelletier, M., Look, D.C., Holtzman, M.J., Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 5680–5685.
9. Rossaint, J., Nadler, J.L., Ley, K., Zarbock, A., Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury. Crit. Care, 16, 2012, R166.
10. Abrial, C., Grassin-Delyle, S., Salvator, H., Brollo, M., Naline, E., Devillier, P., 15-Lipoxygenases regulate the production of chemokines in human lung macrophages. Br. J. Pharmacol. 172 (2015), 4319–4330.
11. Wittwer, J., Hersberger, M., The two faces of the 15-lipoxygenase in atherosclerosis. Prostagl. Leukot. Essent. Fat. Acids 77 (2007), 67–77.
12. Huo, Y., Zhao, L., Hyman, M.C., Shashkin, P., Harry, B.L., Burcin, T., Forlow, S.B., Stark, M.A., Smith, D.F., Clarke, S., Srinivasan, S., Hedrick, C.C., Pratico, D., Witztum, J.L., Nadler, J.L., Funk, C.D., Ley, K., Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation 110 (2004), 2024–2031.
13. Salimi, V., Hennus, M.P., Mokhtari-Azad, T., Shokri, F., Janssen, R., Hodemaekers, H.M., Rygiel, T.P., Coenjaerts, F.E., Meyaard, L., Bont, L., Opioid receptors control viral replication in the airways. Crit. Care Med. 41 (2013), 205–214.
14. Kong, X., Hellermann, G.R., Patton, G., Kumar, M., Behera, A., Randall, T.S., Zhang, J., Lockey, R.F., Mohapatra, S.S., An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virol. J., 2, 2005, 3.
15. Castro, S.M., Guerrero-Plata, A., Suarez-Real, G., Adegboyega, P.A., Colasurdo, G.N., Khan, A.M., Garofalo, R.P., Casola, A., Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am. J. Respir. Crit. Care Med. 174 (2006), 1361–1369.
16. Domachowske, J.B., Bonville, C.A., Rosenberg, H.F., Gene expression in epithelial cells in response to pneumovirus infection. Respir. Res. 2 (2001), 225–233.
17. Tabarani, C.M., Bonville, C.A., Suryadevara, M., Branigan, P., Wang, D., Huang, D., Rosenberg, H.F., Domachowske, J.B., Novel inflammatory markers, clinical risk factors and virus type associated with severe respiratory syncytial virus infection. Pediatr. Infect. Dis. J. 32 (2013), e437–442.
18. Baschuk, N., Wang, N., Watt, S.V., Halse, H., House, C., Bird, P.I., Strugnell, R., Trapani, J.A., Smyth, M.J., Andrews, D.M., NK cell intrinsic regulation of MIP-1α by granzyme M. Cell Death Dis., 5, 2014, e1115.
19. Dioszeghy, V., Rosas, M., Maskrey, B.H., Colmont, C., Topley, N., Chaitidis, P., Kuhn, H., Jones, S.A., Taylor, P.R., O'Donnell, V.B., 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J. Immunol. 181 (2008), 6514–6524.
20. Wen, Y., Gu, J., Chakrabarti, S.K., Aylor, K., Marshall, J., Takahashi, Y., Yoshimoto, T., Nadler, J.L., The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology 148 (2007), 1313–1322.
21. Wen, Y., Gu, J., Vandenhoff, G.E., Liu, X., Nadler, J.L., Role of 12/15-lipoxygenase in the expression of MCP-1 in mouse macrophages. Am. J. Physiol. Heart Circ. Physiol. 294 (2008), H1933–H1938.
22. Jeon, S.G., Moon, H.G., Kim, Y.S., Choi, J.P., Shin, T.S., Hong, S.W., Tae, Y.M., Kim, S.H., Zhu, Z., Gho, Y.S., Kim, Y.K., 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA. Clin. Exp. Allergy 39 (2009), 908–917.
23. Hosakote, Y.M., Jantzi, P.D., Esham, D.L., Spratt, H., Kurosky, A., Casola, A., Garofalo, R.P., Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am. J. Respir. Crit. Care Med. 183 (2011), 1550–1560.
24. Komaravelli, N., Casola, A., Respiratory viral infections and subversion of cellular antioxidant defenses. J pharmacogenomics Pharmacoproteomics, 5(4), 2014, 1000141.
25. Hosakote, Y.M., Komaravelli, N., Mautemps, N., Liu, T., Garofalo, R.P., Casola, A., Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus. Am. J. Physiol. Lung Cell Mol. Physiol. 303 (2012), L991–L1000.
26. Czapski, G.A., Czubowicz, K., Strosznajder, R.P., Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacol. Rep. 64 (2012), 1179–1188.
27. Bolick, D.T., Orr, A.W., Whetzel, A., Srinivasan, S., Hatley, M.E., Schwartz, M.A., Hedrick, C.C., 12/15-lipoxygenase regulates intercellular adhesion molecule-1 expression and monocyte adhesion to endothelium through activation of RhoA and nuclear factor-kappaB. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 2301–2307.
28. Chang, C.H., Huang, Y., Anderson, R., Activation of vascular endothelial cells by IL-1alpha released by epithelial cells infected with respiratory syncytial virus. Cell Immunol. 221 (2003), 37–41.
29. McNamara, P.S., Smyth, R.L., The pathogenesis of respiratory syncytial virus disease in childhood. Br. Med. Bull. 61 (2002), 13–28.
30. Soumya, S.J., Binu, S., Helen, A., Anil Kumar, K., Reddanna, P., Sudhakaran, P.R., Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic. Inflamm. Res. 61 (2012), 707–718.